Hereditary motor and sensory neuropathy (HMSN) IA, developmental delay and autism related disorder in a boy with
U Moog1, J J Engelen, B W Weber
1Department of Clinical Genetics, Research Institute Growth & Development (GROW), Maastricht University, Maastricht, The Netherlands. ute.moog@gen.unimaas.nl
Insights
A de novo duplication on chromosome 17p11.2-p12 in a boy led to developmental delay, autism, and Charcot-Marie-Tooth type 1A (CMT1A) neuropathy. This duplication also caused distinctive facial features, confirming a known genetic syndrome.
Area of Science:
- Genetics
- Neurology
- Developmental Pediatrics
Background:
- Genetic duplications on chromosome 17p are associated with various neurodevelopmental disorders.
- Charcot-Marie-Tooth type 1A (CMT1A) is a peripheral neuropathy often linked to duplications involving the PMP22 gene.
- Smith-Magenis syndrome is a complex genetic disorder characterized by developmental delay and distinctive facial features.
Observation:
- A 6-year-old boy presented with moderate developmental delay, gait disturbance, autism, and mild dysmorphic features.
- Initial cytogenetic analysis revealed a normal karyotype, but further investigation identified a de novo duplication on 17p11.2-p12.
- Neurological examination showed a motor and sensory polyneuropathy, diagnosed as hereditary motor and sensory neuropathy type Ia (HMSN Ia), a form of CMT1A.
Findings:
- Quantitative Southern blot and FISH analysis confirmed a duplication encompassing the PMP22 locus, consistent with HMSN Ia.
- Retrospective GTG banding re-evaluation and FISH analysis specifically for the Smith-Magenis region (17p11.2) revealed the 17p duplication.
- The patient exhibited a recognizable facial phenotype including a broad forehead, hypertelorism, downslanting palpebral fissures, smooth philtrum, thin upper lip, and ear anomalies.
Implications:
- This case reinforces the phenotypic spectrum of 17p11.2-p12 duplications, including psychomotor delay, neurobehavioral issues, and craniofacial anomalies.
- The findings highlight the association between PMP22 locus duplications and HMSN Ia, underscoring the genetic basis of CMT1A.
- The study contributes to understanding the genotype-phenotype correlation in dup(17)(p11.2) and dup(17)(p11.2p12) syndromes, aiding in diagnosis and genetic counseling.
Abstract:
We present a 6-year-old boy with moderate developmental delay, gait disturbance, autism related disorder and mild dysmorphic features. He was seen for evaluation of his retardation since the age of 2.8 years. At first sight, a cytogenetic analysis showed a normal 46,XY karyotype. Neurological examination at the age of 5.5 years revealed a motor and sensory polyneuropathy. A quantitative Southern blot with probes PMP22 and VAW409 specific for Charcot-Marie-Tooth type 1 (CMT1) disclosed a duplication which confirmed the diagnosis HMSN Ia. Subsequently, GTG banded metaphases were re-evaluated and a small duplication 17p was seen on retrospect. Additional FISH with probe LSISMS (Vysis) specific for the Smith-Magenis region at 17p11.2 again showed a duplication. Both parents had a normal karyotype and the duplication test for CMT1 showed normal results for both of them. The boy had a de novo 46,XY,dup(17)(p11.2p12) karyotype. The present observation confirms previous findings of mild psychomotor delay, neurobehavioural features and minor craniofacial anomalies as the major phenotypic features of dup(17)(p11.2) and dup(17)(p11.2p12); in cases of duplications comprising the PMP22 locus HMSN1 is associated. A recognizable facial phenotype emerges characterized by a broad forehead, hypertelorism, downslant of palpebral fissures, smooth philtrum, thin upper lip and ear anomalies.
Related Concept Videos
Meiosis I
Pleiotropy
Sex-linked Disorders
Genomic Imprinting and Inheritance
The expression of some genes depends on which parent passed the gene to the offspring, through a phenomenon known as...
Autism Spectrum Disorder
These core symptoms manifest differently among individuals, ranging from mild to severe. The disorder's complexity extends beyond its clinical presentation, encompassing a diverse range of biological, cognitive, and sociocultural influences.
Huntington Disease l: Introduction


